129 related articles for article (PubMed ID: 10841200)
1. An update on prostate cancer research.
Small EJ; Reese DM
Curr Opin Oncol; 2000 May; 12(3):265-72. PubMed ID: 10841200
[TBL] [Abstract][Full Text] [Related]
2. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
Nair B; Wilt T; MacDonald R; Rutks I
Cochrane Database Syst Rev; 2002; (1):CD003506. PubMed ID: 11869665
[TBL] [Abstract][Full Text] [Related]
3. Advances in prostate cancer.
Small EJ
Curr Opin Oncol; 1999 May; 11(3):226-35. PubMed ID: 10328599
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer.
Small EJ
Curr Opin Oncol; 1997 May; 9(3):277-86. PubMed ID: 9229151
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of serum markers for prostate cancer.
Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of J-CAPRA score for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy.
Akakura K; Tsuji H; Suzuki H; Ichikawa T; Ishikawa H; Okada T; Kamada T; Harada M; Tsujii H; Shimazaki J
Jpn J Clin Oncol; 2014 Apr; 44(4):360-5. PubMed ID: 24585931
[TBL] [Abstract][Full Text] [Related]
7. Future prospects in prostate cancer.
Hegarty NJ; Fitzpatrick JM; Richie JP; Scardino PT; deVere White RW; Schröder FH; Coffey DS
Prostate; 1999 Sep; 40(4):261-8. PubMed ID: 10420155
[TBL] [Abstract][Full Text] [Related]
8. Current management of advanced and castration resistant prostate cancer.
Gomella LG; Petrylak DP; Shayegan B
Can J Urol; 2014 Apr; 21(2 Supp 1):1-6. PubMed ID: 24775717
[TBL] [Abstract][Full Text] [Related]
9. [Adenocarcinoma of the prostate].
Dvorácek J
Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and Active Treatment versus Active Surveillance of Localized Prostate Cancer in Renal Transplant Patients in the Era of Low and Very Low Risk Prostate Cancer.
Aminsharifi A; Simon R; Polascik TJ; Robertson CN; Sudan DL; Collins BH; Moul JW
J Urol; 2019 Sep; 202(3):469-474. PubMed ID: 30835631
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer update: 2005.
Ryan CJ; Small EJ
Curr Opin Oncol; 2006 May; 18(3):284-8. PubMed ID: 16552242
[TBL] [Abstract][Full Text] [Related]
12. The role of androgen deprivation in the definitive management of clinically localized prostate cancer treated with radiation therapy.
Vicini FA; Kini VR; Spencer W; Diokno A; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):707-13. PubMed ID: 10098424
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy in high-risk prostate cancer.
Shevach J; Chaudhuri P; Morgans AK
Clin Adv Hematol Oncol; 2019 Jan; 17(1):45-53. PubMed ID: 30843898
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and Prognostic Factors in Men Receiving Androgen Deprivation Therapy for Prostate Cancer Recurrence after Radical Prostatectomy.
Ravi P; Karnes RJ; Rangel LJ; Pagliaro LC
J Urol; 2018 Nov; 200(5):1075-1081. PubMed ID: 29709664
[TBL] [Abstract][Full Text] [Related]
15. Predicting high-risk disease using tissue biomarkers.
Donovan MJ; Cordon-Cardo C
Curr Opin Urol; 2013 May; 23(3):245-51. PubMed ID: 23478499
[TBL] [Abstract][Full Text] [Related]
16. The changing natural history of metastatic prostate cancer.
Alva A; Hussain M
Cancer J; 2013; 19(1):19-24. PubMed ID: 23337753
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.
Haines IE; Gabor Miklos GL
J Natl Cancer Inst; 2013 Oct; 105(20):1534-9. PubMed ID: 24092918
[TBL] [Abstract][Full Text] [Related]
18. [High-risk clinically localised prostate cancer].
Rozet F; Cornu JN; Cussenot O; Fromont G; Hennequin C
Bull Cancer; 2010 Dec; 97(12):1517-36. PubMed ID: 21220228
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer: measuring PSA.
Pezaro C; Woo HH; Davis ID
Intern Med J; 2014 May; 44(5):433-40. PubMed ID: 24816306
[TBL] [Abstract][Full Text] [Related]
20. Screening for prostate cancer: an updated review.
Marta GN; Hanna SA; Fernandes da Silva JL; Carvalho Hde A
Expert Rev Anticancer Ther; 2013 Jan; 13(1):101-8. PubMed ID: 23259431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
